Biotechnology
Tibotec Therapeutics today announced the availability of a new 600 mg tablet strength for PREZISTA , a protease inhibitor . The new dosage strength was approved by the U.S. Food and Drug Administration on February 25, 2008. The recommended oral dose of P
03:03 May 19, 2008
Tengion, Inc., a clinical stage biotechnology company focused on the development of neo-organs and neo-vessels, presented preclinical efficacy data for its Tengion Neo-Bladder Replacement at the Annual Meeting of the American Urological Association inOrl
03:03 May 19, 2008
Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at Citigroup's Global Healthcare Conference on May 22, 2008 at 8:30 a.m. Eastern Time at the Hilton New York Hotel inNew York City. Robert E. Hoffman, Arena's Vice Presi
03:03 May 19, 2008
InterMune, Inc. today announced that its program for the development of pirfenidone for the treatment of idiopathic pulmonary fibrosis has received "Fast Track" designation from the U.S. Food and Drug Administration . Fast Track is a designatio
03:03 May 19, 2008
Karolinska Hospital in Stockholm will become the first inSweden to offer cancer patients advanced RapidArc treatments from Varian Medical Systems . Three RapidArc systems have been ordered along with four replacement Clinac linear accelerators as moves c
03:03 May 19, 2008
WaferGen Biosystems, Inc. , a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today highlighted important developments and corporate milestones achieved since the completion of the year ende
03:03 May 19, 2008
New study results indicated that treatment with AMITIZA® 8 mcg lead to significant relief of overall symptoms of Irritable Bowel Syndrome with Constipation . These results were presented at Digestive Disease Week 2008, the largest annual internation
03:00 May 19, 2008
Intellect Neurosciences, Inc. , a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease , announced today that it has entered into a license agreement with Wyeth a
02:53 May 19, 2008
IPSOGEN SA , a cancer profiler that develops and markets molecular diagnostic assays for blood & breast cancers, announced today that researchers from the University of Texas MD Anderson Cancer Center will present the results of two studies on the Ge
02:33 May 19, 2008
Pharmasset, Inc. has nominated PSI-7851 as a lead development candidate for the treatment of chronic hepatitis C virus . PSI-7851 is a proprietary nucleotide analogue polymerase inhibitor of HCV that is being advanced into Good Laboratory Practice animal
02:13 May 19, 2008
Sangamo BioSciences, Inc. announced today the presentation of data from a Phase 1 clinical trial of a zinc finger DNA-binding protein activator of vascular endothelial growth factor in subjects with critical limb ischemia . The data demonstrate that admi
02:03 May 19, 2008
Advance Nanotech, Inc. today reported financial results for its first quarter ended March 31, 2008. This quarter was the first, full fiscal period since the Company refocused its business model from managing the development of a portfolio of early-stage
02:03 May 19, 2008
Collaborative Software Initiative , the company that brings like-minded organizations together to work on collaborative software at a fraction of the cost, today announced the release of the first open source, web-based infectious disease reporting and m
02:03 May 19, 2008
WaferGen Biosystems, Inc. , a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced the signing of two separate private placements. The details of the financings, which have not ye
02:03 May 19, 2008
Cypress Bioscience, Inc. today announced that Michael R. Hufford, PhD, its Vice President of Corporate Development, will present at the Citi Investment Research Global Health Care Conference on Thursday, May 22, 2008.
01:30 May 19, 2008
Direct Medical Systems has established an office inRussia to open a distribution network covering all of Russia. This partnership has resulted in the registration of DMS's InNovaSound USB Ultrasound Systems and volume sales to a number of medical provide
00:23 May 19, 2008
MorphoSys AG announced today that Schering-Plough Corporation has decided to extend the current collaboration between the two companies for one year. The collaboration, announced in May 2006, has a maximum term of 5 years until 2011 and may be extended
20:40 May 18, 2008
Specialist Pharmaceutical Company Pharmaxis Ltd today announced that it has received national approval to market Aridol inGermany.
17:23 May 18, 2008
Roche today announced results from the LATINO study, the largest prospective study to evaluate the response of Latino whites infected with genotype 1 hepatitis C virus to combination therapy with pegylated interferon plus ribavirin. The results showed PE
14:23 May 18, 2008
In two papers published today, deCODE scientists and academic colleagues fromEurope and the U.S. expand upon the company's recent findings in the genetics of pigmentation traits in people of European descent, and demonstrate that certain of these common
08:03 May 18, 2008
43879 - 43898 of 48601 Stories
<<
<
Next 20 Biotechnology
>
>>